These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 697603)

  • 1. Protein-rich cytoplasmic bodies of substantia nigra and locus ceruleus. A comparative study in parkinsonian and normal brain.
    Issidorides MR; Mytilineou C; Whetsell WO; Yahr MD
    Arch Neurol; 1978 Oct; 35(10):633-7. PubMed ID: 697603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fine structure of neuronal spherical arginine-rich bodies of substantia nigra and locus coeruleus in the human brain.
    Issidorides MR; Pappas GD
    Hum Neurobiol; 1988; 6(4):239-46. PubMed ID: 2832354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Incidental occurrence of Lewy bodies in the brains of elderly patients--the relevance to aging and Parkinson's disease].
    Wakabayashi K; Takahashi H; Oyanagi K; Ikuta F
    No To Shinkei; 1993 Nov; 45(11):1033-8. PubMed ID: 8135950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Light- and electron-microscopic studies of intracytoplasmic acidophilic granules in the human locus ceruleus and substantia nigra.
    Sekiya S; Tanaka M; Hayashi S; Oyanagi S
    Acta Neuropathol; 1982; 56(1):78-80. PubMed ID: 6278812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lewy bodies in parkinsonism share components with intraneuronal protein bodies of normal brains.
    Issidorides MR; Mytilineou C; Panayotacopoulou MT; Yahr MD
    J Neural Transm Park Dis Dement Sect; 1991; 3(1):49-61. PubMed ID: 1712207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease.
    Sasaki M; Shibata E; Tohyama K; Takahashi J; Otsuka K; Tsuchiya K; Takahashi S; Ehara S; Terayama Y; Sakai A
    Neuroreport; 2006 Jul; 17(11):1215-8. PubMed ID: 16837857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mercury is present in neurons and oligodendrocytes in regions of the brain affected by Parkinson's disease and co-localises with Lewy bodies.
    Pamphlett R; Bishop DP
    PLoS One; 2022; 17(1):e0262464. PubMed ID: 35015796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Explant cultures of catecholamine-containing neurons from rat brain: biochemical, histofluorescence, and electron microscopic studies.
    Schlumpf M; Shoemaker WJ; Bloom FE
    Proc Natl Acad Sci U S A; 1977 Oct; 74(10):4471-5. PubMed ID: 270693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurofilament mRNA is reduced in Parkinson's disease substantia nigra pars compacta neurons.
    Hill WD; Arai M; Cohen JA; Trojanowski JQ
    J Comp Neurol; 1993 Mar; 329(3):328-36. PubMed ID: 8459049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of two antigens in parkinsonian Lewy bodies.
    Hirsch E; Ruberg M; Portier MM; Dardenne M; Agid Y
    Brain Res; 1988 Feb; 441(1-2):139-44. PubMed ID: 3359227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization of phospholipids in human catecholamine neurons with Baker's acid haematein.
    Panayotacopoulou MT; Boukis D; Issidorides MR
    J Neurocytol; 1989 Oct; 18(5):593-7. PubMed ID: 2482342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of cell size and nucleolar size in Lewy body containing neurons of substantia nigra in Parkinson's disease.
    Gertz HJ; Siegers A; Kuchinke J
    Brain Res; 1994 Feb; 637(1-2):339-41. PubMed ID: 8180816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depigmentation in the nerve cells of the substantia nigra and locus ceruleus in Parkinsonism.
    Forno LS; Alvord EC
    Adv Neurol; 1974; 5():195-202. PubMed ID: 4374062
    [No Abstract]   [Full Text] [Related]  

  • 14. Colloid (hyaline) inclusion bodies in the central nervous system: their presence in the substantia nigra is diagnostic of Parkinson's disease.
    Pappolla MA; Shank DL; Alzofon J; Dudley AW
    Hum Pathol; 1988 Jan; 19(1):27-31. PubMed ID: 2447008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of neuropathology in Parkinson's disease subjects with and without deep brain stimulation.
    Pal GD; Ouyang B; Serrano G; Shill HA; Goetz C; Stebbins G; Metman LV; Driver-Dunckley E; Mehta SH; Caviness JN; Sabbagh MN; Adler CH; Beach TG;
    Mov Disord; 2017 Feb; 32(2):274-277. PubMed ID: 27911008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibodies raised against Lewy bodies in brains from subjects with Parkinson's disease.
    Hirsch E; Ruberg M; Dardenne M; Portier MM; Javoy-Agid F; Bach JF; Agid Y
    Brain Res; 1985 Oct; 345(2):374-8. PubMed ID: 2994847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p35nck5a and cyclin-dependent kinase 5 colocalize in Lewy bodies of brains with Parkinson's disease.
    Nakamura S; Kawamoto Y; Nakano S; Akiguchi I; Kimura J
    Acta Neuropathol; 1997 Aug; 94(2):153-7. PubMed ID: 9255390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An early cytoplasmic change before Lewy body maturation: an ultrastructural study of the substantia nigra from an autopsy case of juvenile parkinsonism.
    Hayashida K; Oyanagi S; Mizutani Y; Yokochi M
    Acta Neuropathol; 1993; 85(4):445-8. PubMed ID: 8480516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substantia nigra Marinesco bodies are associated with decreased striatal expression of dopaminergic markers.
    Beach TG; Walker DG; Sue LI; Newell A; Adler CC; Joyce JN
    J Neuropathol Exp Neurol; 2004 Apr; 63(4):329-37. PubMed ID: 15099023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dementia without Alzheimer pathology.
    Heilig CW; Knopman DS; Mastri AR; Frey W
    Neurology; 1985 May; 35(5):762-5. PubMed ID: 2986048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.